Pharmacokinetic and Safety Trial to Determine the Appropriate Dose for Pediatric Patients With Multidrug Resistant Tuberculosis
Clinical trial NCT01856634 · COMPLETED
Trial details
- NCT number
- NCT01856634
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-14
- Primary completion
- 2017-12-10
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.